Health Condition 1: D34- Benign neoplasm of thyroid gland
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria 1.ASA I, II patients, 2.Body mass index between 18-30 kg/m2, 3.Patients posted for surgery for benign thyroid conditions will be included in this study.
Exclusion criteria
Exclusion criteria: Exclusion criteria 1.Patients refusal to participate in the study, 2.Perioperative blood transfusions, 3.Chronic opioid use, 4.Renal failure, 5.Liver failure, 6.Congestive heart failure and 7.Hematological diseases will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary end point of the study will be effect of different FiO2 on NK cell count (CD56, CD6)Timepoint: Perioperative | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary end points will be effect of different FiO2 on a. The total T lymphocyte count and counts for the T lymphocyte subpopulations, CD3, CD4, CD8, CD19, Th1 and Th2cells. b. Postoperative complications in patients undergoing surgery for thyroid surgeries. Timepoint: Perioperative | — |
Countries
India
Contacts
Nizams Institute of Medical Sciences